Table 4.
Outcomes.
| Outcome (N = 247) | n (%) or median days (IQR) |
|---|---|
| Mortality | |
| All-cause mortality, n (%) | 32/247 (13) |
| Cardiovascular mortality, n (%) | 3/247 (1.2) |
| Median number of days from symptom onset to death (IQR) | 19 days (12.5–28) |
| Median number of days from admission to death (IQR) | 12.5 days (8–22) |
| Cardiovascular events | |
| Myocardial Infarction, n%) | 12/247 (4.9) |
| Type 1 myocardial infarction, n (%) | 0 (0) |
| Type 2 myocardial infarction n (%) | 12/247 (100) |
| ST-segment elevation myocardial infarction, n (%) | 0 (0) |
| Coronary angiogram, n (%) | 0 (0) |
| Percutaneous coronary intervention performed, n (%) | 0 (0) |
| Thrombolysis, n (%) | 0 (0) |
| Stoke, n (%) | 1/247 (0.4) |
| Stress cardiomyopathy, n (%) | 3/247 (1.2) |
| Acute Heart failure, n (%) | 19/247 (7.7) |
| Myocarditis, n (%) | 1/247 (0.4) |
| New Atrial fibrillation/flutter, n (%) | 21/247 (8.5) |
| Ventricular tachycardia, n (%) | 23/247 (9.3) |
| Other arrhythmia, n (%) | 10/247 (4) |
| Pericarditis, n (%) | 2/247 (0.8) |
| Coronary vasospasm, n (%) | 1/247 (0.4) |
| Venous thromboembolism, n (%) | 12/247 (4.9) |
| CT pulmonary angiogram or venous doppler ultrasound of extremity performed, n (%) | 57/247 (23.1) |
| Median d dimer in those without venous thromboembolism diagnosed, (IQR) | 1595 (996–3971) |
| Median d dimer in those with diagnosed venous thromboembolism (IQR) | 5761 (3374–9955) |
| CT pulmonary angiogram performed, n (%) | 33/247 (13.4) |
| Pulmonary embolism diagnosed, n (%) | 4/33 (12.1) |
| Median D dimer in those without pulmonary embolism diagnosed (IQR) | 1248 (986–3087) |
| Median D dimer in those with diagnosed pulmonary embolism (IQR) | 43,993 (23,076–64,910) |
| Extremity venous doppler ultrasonography performed, n (%) | 38/247 (15.4) |
| Deep vein thrombosis diagnosed, n (%) | 8/38 (21.1) |
| Median D dimer in those without deep vein thrombosis (IQR) | 2236 (1268–5654) |
| Median D dimer in those with deep vein thrombosis (IQR) | 5761 (4039–7430) |
| Renal outcomes | |
| Acute renal injury, n (%) | 86 (34.8) |
| Acute renal injury requiring renal replacement therapy, n (%) | 17 (6.9) |
| ICU specific outcomes (n = 103) | |
| Admitted to ICU, n (%) | 103/247 (41.7) |
| Transferred to the ICU from hospital floor service, n (%) | 46/190 (24.2) |
| Median days from symptom onset to ICU admission, days (IQR) | 7.5 days (6.25–10) |
| Median days from admission to ICU transfer (n = 46), (IQR) | 2 days (1–3.8) |
| Requirement for vasopressors, n (%) | 91/103 (88.3) |
| Intubated, n (%) | 90/103 (87.4) |
| Extubated, n (%) | 71/90 (78.9) |
| Median number of days from intubation to extubation (IQR) | 15 days (8.5–22) |
| Median number of days from intubation to death, (IQR) | 13 (8.3–21.8) |
| Acute Respiratory Distress Syndrome, n (%) | 90/103 (87.4) |
| Mild, n (%) | 10/90 (11.1) |
| Moderate, n (%) | 57/90 (63.3) |
| Severe, n (%) | 23/90 (25.6) |
| Prone positioning, n (%) | 54/103 (52.4) |
| Paralytic infusion, n (%) | 39/103 (37.9) |
| Extracorporeal membrane oxygenation, n (%) | 4/103 (3.9) |
| Cardiogenic shock, n (%) | 4/103 (3.9) |
| Hemorrhagic shock, n (%) | 1/103 (1) |
| Mixed shock, n (%) | 6/103 (5.8) |
| Percutaneously inserted ventricular assist device, n (%) | 1/103 (1) |
| Intra-aortic balloon pump, n (%) | 0/103 (0) |
| Remains in ICU, n (%) | 1/103 (1) |
| Discharged from ICU alive, n (%) | 79/103 (76.7) |
| Median number of days in ICU for those discharged from ICU alive (IQR) | 15 (5–24.5) |
| Discharged from ICU dead, n (%) | 23/103 (22.3) |
| Median number of days spent in ICU for those discharged from ICU deceased (IQR) | 13 (9–22) |
| Discharge status (N = 247) | |
| Remains admitted, n (%) | 2/247 (1) |
| Discharged alive, n (%) | 213/247 (86.2) |
| Median days from admission to discharge, (IQR) | 9 (5–18) |
| Discharge Location | 213 (86.2) |
| Home, n (%) | 143 (67.1) |
| Skilled nursing facility, n (%) | 18 (8.5) |
| Rehabilitation facility, n (%) | 26 (12.2) |
| Long term acute care facility, n (%) | 25 (11.7) |
| Other, n (%) | 1 (0.5) |